CAMP4 Therapeutics Corporation (CAMP) Financials

CAMP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 93.4 million 94.1 million
March 31, 2026 105.5 million 74.6 million
Dec. 31, 2025 117.8 million 70.1 million
Sept. 30, 2025 86.4 million 27.7 million

CAMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.8 million 1.9 million
March 31, 2026 -11.0 million 1.5 million
Dec. 31, 2025 6.3 million 1.2 million
Sept. 30, 2025 -11.2 million 984000

CAMP Net Income

No data available :(

CAMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 86.4 million 1.6 million -
March 31, 2026 99.2 million 1.7 million 2.1 million
Dec. 31, 2025 109.5 million - 1.7 million
Sept. 30, 2025 75.3 million 3.0 million 6.3 million

CAMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 57.9 million
Dec. 31, 2025 51.9 million
Sept. 30, 2025 20.2 million

CAMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 129000 10.8 million 4.3 million -
March 31, 2026 - 9.6 million 4.2 million -
Dec. 31, 2025 - 8.4 million 4.8 million -
Sept. 30, 2025 - 9.4 million 4.6 million -

CAMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.8 million -
March 31, 2026 1.3 million 520000
Dec. 31, 2025 348000 372000
Sept. 30, 2025 795000 416000

CAMP Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CAMP

Price: $5

52 week price:
1.32
7.75

Earnings Per Share: -2.35 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 144300

Ebitda: 23.8 million

Market Capitalization: 341.4 million

Links: